Brief: Recordati Q1 2026 Revenue EUR 713.4 Million, Up 4.9% YoY
April 29 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI: Q1 2026 REVENUE €713.4 MILLION, UP 4.9% VERSUS Q1 2025 Q1 REVENUE UP 8.7% Y/Y ON A LIKE-FOR-LIKE BASIS AND AT CONSTANT EXCHANGE RATES Q1 REVENUE SAW ADVERSE FX IMPACT OF EUR 29.1 MILLION Further company coverage: RECI.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Recordati Industria Chimica e Farmaceutica
See all newsItaly - Factors to watch on October 26
Deals of the day-Mergers and acquisitions
Brief: Recordati Says 66.67% Threshold Condition In Recordati Fulfilled
Brief: Recordati - CVC Capital Partners IX Aggregator Holds 19,189,219 Recordati Shares, 9.18% Of Share Capital
CVC, GBL hold 74.3% of Italian drugmaker Recordati at end of takeover offer period